Anousha Pharmaceuticals Company

Name

Anousha Pharmaceuticals Company

Legal name

Anousha Pharmaceuticals Company (شرکت داروسازی آنوشا)

Website

https://tasnimpharma.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industry

Gastroenterology & Hepatology Pharmaceuticals (HLAIAAAI)

Keywords

• Prescription pharmaceuticals
• Generic drug manufacturing
• Gastroenterology medications
• OTC health products
• Pharmaceutical distribution

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Manufactures and sells prescription drugs (نسخه‌ها), OTC products (محصولات OTC), vitamins, and dietary supplements through pharmacy and hospital distribution channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Anousha Pharmaceuticals Company manufactures and distributes a broad portfolio of generic prescription (Rx) medicines, over-the-counter (OTC) products, and vitamins and dietary supplements across Iran. Its portfolio spans gastroenterology, nephrology and urology, cardiology, anti-infectives, endocrinology, and CNS/neurology therapeutic areas, with selected gastroenterology products built on proprietary MMX multi-particulate controlled-release technology.

Product overview

Anousha Pharmaceuticals Company is a pharmaceutical manufacturer producing a wide range of products across multiple therapeutic categories. The portfolio includes prescription drugs, OTC (over-the-counter) products, vitamins, and dietary supplements. Key product lines span gastroenterology (with MMX technology for colon-targeted drug delivery), nephrology and urology, cardiology, anti-infectives (including Minocycline and Tetracycline antibiotics), endocrinology, and CNS/neurology. Named sub-brands include Normskin (isotretinoin for acne/rosacea), Terravex (dutasteride for dermatological applications), and supplementary tablet products. The company operates primarily in the Iranian pharmaceutical market and maintains a patient support hotline.

Differentiator

Problem solved

Functional benefit

Brands

• Anousha (آنوشا): Primary brand name of the pharmaceutical company, producing prescription drugs, OTC products, vitamins, and supplements.
• Tasnim (تنسیم)
• Normskin (نورم‌اسکین)
• Terravex (تراوکس)

Products and services

• Prescription (Rx) Generic Medicines

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• TPGS (Tolid Pharmaceutical Group Saba): Iranian pharmaceutical manufacturer with GMP-compliant facilities producing generic and specialty drugs across multiple therapeutic areas. Directly comparable as a domestic producer competing in similar pharmacy and hospital channels.
• Sobhan Pharmaceuticals: Iranian pharmaceutical company producing a diversified portfolio of prescription and OTC products through pharmacy and hospital channels. Comparable in business model, therapeutic breadth, and Iranian market positioning.
• Barakat Pharmaceutical Group: Major Iranian pharmaceutical group manufacturing generic and branded drugs across therapeutic categories including cardiology, gastroenterology, and infectious disease. Comparable as a domestic multi-therapy manufacturer operating in the same regulatory and distribution environment.
• Darou Pakhsh Pharma Manufacturing Company: One of Iran's largest domestic pharmaceutical manufacturers producing a broad range of prescription drugs, OTCs, and supplements across multiple therapeutic areas. Most directly comparable Iranian counterpart to Anousha given similar horizontal portfolio and domestic distribution model.

Broad incumbents

• Dr. Reddy's Laboratories: Diversified Indian pharmaceutical company producing generics, OTCs and specialty products across therapeutic areas including gastroenterology and dermatology. Comparable in horizontal multi-therapy portfolio approach and emerging-market focus.
• Cipla Limited: Global Indian pharmaceutical company with deep emerging-market presence producing affordable prescription drugs, OTCs, and APIs across therapeutic areas. Comparable as a horizontally diversified emerging-market pharma serving similar value-tier prescription demand.

Regional players

• Julphar (Gulf Pharmaceutical Industries): Largest pharmaceutical manufacturer in the UAE producing generics, OTCs, and specialty products across similar therapeutic categories. Comparable as a regional MENA player with multi-therapy portfolio and pharmacy distribution, though serving different geography.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Major Saudi pharmaceutical manufacturer with broad therapeutic portfolio across prescription and OTC categories. Comparable as a regional MENA peer operating similar horizontal specialty business model across the Gulf.
• EIPICO (Egyptian International Pharmaceutical Industries Company): One of the largest pharmaceutical manufacturers in the MENA region producing generics and specialty drugs across multiple therapeutic areas. Comparable as a regional peer with broad horizontal portfolio and pharmacy/hospital distribution.

Emerging players

• Cosmo Pharmaceuticals: Specialty pharma company that originated the MMX (Multi Matrix System) colon-targeted drug delivery platform used in products like Lialda/Mezavant for IBD. If Anousha licenses MMX, Cosmo is the most relevant technology and licensor peer, comparable through shared platform dependency.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/tasnim-pharmaceutical-co

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anousha Pharmaceuticals Company